Video: New Mutual Fund? Better Off Waiting
T. Rowe Price introduced its new Large-Cap Core Fund this week. MarketWatch's Chuck Jaffe says there's no need for investors to jump in just yet.
Video: New Mutual Fund? Better Off Waiting
T. Rowe Price introduced its new Large-Cap Core Fund this week. MarketWatch's Chuck Jaffe says there's no need for investors to jump in just yet.
Revenue Recognition: Will a Single Model Fly?
Elements unique to long-term contracts pose a challenge for FASB and IASB in their bid to create one standard covering all customer relationships.
Twice the Effort for a Revolver: A Good Deal
It took some doing, but Ducommun is among the few companies able to recently acquire a five-year line of credit with decent terms.
CFOs on the Move: Week Ending July 3
Facebook, eGistics, Spansion, Charles & Colvard, NeuStar, Cumulus Media, QL2 Software, Century Payments, SeaBright Insurance Holdings, Aspen Technology, Akebia Therapeutics.
Banks Take Aim at Revolvers
With lenders shrinking the length and size of their commitments to companies and charging more, liquidity risk is rising.
Will Whopping Goodwill Hits Hurt Deals?
The big question for many investors is whether the backlash from past mergers will cool deal valuations going forward.
Treasurers Cling to Safety
When it comes to short-term investments during the downturn, treasury departments see protecting their principal, rather than making money, as a top priority.
Leadership in Finance: ICE Energy’s David Schwarzbach
The unlikely CFO moved from agriculture to activist to financial anchor for a burgeoning technology company.
Citigroup Ready to Swallow a “Tax Poison Pill”
In its recently announced stock swap deal with the government, Citi is looking to keep a poison pill handy to prevent a technical change of ownership.